{
    "eid": "2-s2.0-85113521622",
    "title": "Potential for developing plant-derived candidate vaccines and biologics against emerging coronavirus infections",
    "cover-date": "2021-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Molecular Biology",
            "@code": "1312",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Immunology and Microbiology (all)",
            "@code": "2400",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Biopharmaceuticals",
        "Coronavirus",
        "COVID-19",
        "Molecular farming",
        "Plant expression",
        "Recombinant proteins",
        "SARS-CoV-2"
    ],
    "authors": [
        "Balamurugan Shanmugaraj",
        "Konlavat Siriwattananon",
        "Ashwini Malla",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 13,
    "ref-count": 135,
    "ref-list": [
        "Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003",
        "A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster",
        "Molecular pathology of emerging coronavirus infections",
        "Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)",
        "Receptor-binding domain as a target for developing SARS vaccines",
        "Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Emerging Zoonotic Respiratory Pathogen in Humans",
        "Recent advances in (therapeutic protein) drug development",
        "Plant molecular farming: A viable platform for recombinant biopharmaceutical production",
        "Therapeutic recombinant protein production in plants: Challenges and opportunities",
        "Potential of plants to produce recombinant protein products",
        "Current state-of-the-art in plant-based antibody production systems",
        "Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice",
        "The production of hemagglutininbased virus-like particles in plants: A rapid, efficient and safe response to pandemic influenza",
        "Plant-based vaccines for animals and humans: Recent advances in technology and clinical trials",
        "Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development",
        "The Molecular Biology of Coronaviruses",
        "A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: Lessons from other pathogenic viruses",
        "Structure, function, and evolution of coronavirus spike proteins",
        "Coronavirus vaccine development: From SARS and MERS to COVID-19",
        "Origin and evolution of pathogenic coronaviruses",
        "A pneumonia outbreak associated with a new coronavirus of probable bat origin",
        "The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak",
        "SARS and MERS: Recent insights into emerging coronaviruses",
        "A novel coronavirus from patients with pneumonia in China, 2019",
        "Angiotensin-converting enzyme 2 in lung diseases",
        "Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis",
        "Does SARS-CoV-2 bind to human ACE2 more strongly than does SARS-CoV?",
        "Middle East respiratory syndrome (MERS)",
        "The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies",
        "Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4",
        "Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome",
        "Development and application of therapeutic antibodies against COVID-19",
        "Development of therapeutic antibodies for the treatment of diseases",
        "A randomized, controlled trial of ZMapp for ebola virus infection",
        "Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: Rationale and mechanisms of action",
        "Anti-SARS-CoV-2 neutralizing monoclonal antibodies: Clinical pipeline",
        "Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants",
        "Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association",
        "Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein",
        "Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of Severe acute respiratory syndrome coronavirus",
        "Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants",
        "Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters",
        "Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27",
        "Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV infection",
        "Monoclonal antibodies B38 and H4 produced in Nicotiana benthamiana neutralize SARS-CoV-2 in vitro",
        "REGN COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters",
        "A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2",
        "Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein",
        "The spike protein of SARS-CoV\u2013a target for vaccine and therapeutic development",
        "Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the middle east respiratory syndrome coronavirus spike glycoprotein to avoid neutralization escape",
        "A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2",
        "A human monoclonal antibody blocking SARS-CoV-2 infection",
        "Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody",
        "Antibody responses to individual proteins of SARS coronavirus and their neutralization activities",
        "Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution",
        "Plant-produced receptor-binding domain of SARS-CoV-2 elicits potent neutralizing responses in mice and non-human primates",
        "Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: Implication for vaccine design",
        "Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection",
        "RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response",
        "A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates",
        "Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: A phase 1, open-label, single-arm, dose-escalation trial",
        "Recombinant receptor-binding domains of multiple Middle East respiratory syndrome coronaviruses (MERS-CoVs) induce cross-neutralizing antibodies against divergent human and camel MERS-CoVs and antibody escape mutants",
        "Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: A randomised, double-blind, placebo-controlled, phase 1/2 clinical trial",
        "Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: A double-blind, randomised, phase 1 trial",
        "Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults",
        "Safety and immunogenicity of two RNA-based COVID-19 vaccine candidates",
        "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomised controlled trial",
        "Recombinant protein therapeutics-success rates, market trends and values to 2010",
        "The expression of a nopaline synthase\u2014 Human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue",
        "Molecular pharming\u2019s foot in the FDA\u2019s door: Protalix\u2019s trailblazing story",
        "Biotechnological insights on the expression and production of antimicrobial peptides in plants",
        "Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants",
        "Engineering, Expression in Transgenic Plants and Characterisation of E559, a Rabies Virus-Neutralising Monoclonal Antibody",
        "Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro",
        "Expression and functional evaluation of recombinant anti-receptor activator of nuclear factor kappa-B ligand monoclonal antibody produced in Nicotiana benthamiana",
        "Inactivation of the \u03b2(1,2)-xylosyltransferase and the \u03b1(1,3)-fucosyltransferase genes in Nicotiana tabacum BY-2 Cells by a Multiplex CRISPR/cas9 strategy results in glycoproteins without plant-specific glycans",
        "Characterization of a chemically modified plant cell culture expressed human a-Galactosidase-A enzyme for treatment of Fabry disease",
        "Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana",
        "Addressing demand for recombinant biopharmaceuticals in the COVID-19 era",
        "Transient expression of hemagglutinin antigen from canine influenza virus H3N2 in Nicotiana benthamiana and Lactuca sativa",
        "Transient Protein Expression by Agroinfiltration in Lettuce",
        "Transient expression of beta-glucuronidase in Arabidopsis thaliana leaves and roots and Brassica napus stems using a pneumatic particle gun",
        "Transient Transformation of A. thaliana Seedlings by Vacuum Infiltration",
        "Comparison of microbial and transient expression (tobacco plants and plant-cell packs) for the production and purification of the anticancer mistletoe lectin viscumin",
        "Transient expression of etanercept therapeutic protein in tobacco (Nicotiana tabacum L.)",
        "Development of plant-produced recombinant ACE2-Fc fusion protein as a potential therapeutic agent against SARS-CoV-2",
        "Plant-produced recombinant Osteopontin-Fc fusion protein enhanced osteogenesis",
        "Plant-produced anti-enterovirus 71 (EV71) monoclonal antibody efficiently protects mice against EV71 infection",
        "Structural and in vitro functional analyses of novel plant-produced anti-Human PD1 antibody",
        "Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems",
        "Transient plant transformation mediated by Agrobacterium tumefaciens: Principles, methods and applications",
        "Transient expression systems for plantderived biopharmaceuticals",
        "Optimization of conditions for transient Agrobacterium-mediated gene expression assays in Arabidopsis",
        "Transient expression assay by agroinfiltration of leaves",
        "Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1",
        "An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles",
        "Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana",
        "Contributions of the international plant science community to the fight against human infectious diseases\u2014 Part 1: Epidemic and pandemic diseases",
        "Contributions of the international plant science community to the fight against infectious diseases in humans\u2014Part 2: Affordable drugs in edible plants for endemic and re-emerging diseases",
        "Innovation in plant-based transient protein expression for infectious disease prevention and preparedness",
        "Transformation of an edible crop with the pagA gene of Bacillus anthracis",
        "Low Cost Tuberculosis Vaccine Antigens in Capsules: Expression in Chloroplasts, Bio-Encapsulation, Stability and Functional Evaluation In Vitro",
        "Severe acute respiratory syndrome (SARS) S protein production in plants: Development of recombinant vaccine",
        "Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice",
        "Success stories in molecular farming-a brief overview",
        "A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults",
        "Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18\u201364 years) and older adults (\u226565 years): Two multicentre, randomised phase 3 trials",
        "Plant-based vaccines against respiratory diseases: Current status and future prospects",
        "Accumulation of recombinant SARS-CoV spike protein in plant cytosol and chloroplasts indicate potential for development of plant-derived oral vaccines",
        "Antigen production in plant to tackle infectious diseases flare up: The case of SARS",
        "Pilot production of SARS-CoV-2 related proteins in plants: A proof of concept for rapid repurposing of indoor farms into biomanufacturing facilities",
        "Current updates and research on plant-based vaccines for coronavirus disease 2019",
        "Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19",
        "Safety, immunogenicity and protection provided by unadjuvanted and adjuvanted formulations of recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in non-human primates",
        "Viral targets for vaccines against COVID-19",
        "The Nucleocapsid Protein of SARS-CoV-2: A Target for Vaccine Development",
        "Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets",
        "Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine",
        "Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice",
        "Extremely high-level and rapid transient protein production in plants without the use of viral replication",
        "SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients",
        "Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis",
        "Potential applications of plant biotechnology against SARS-CoV-2",
        "Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations",
        "Advanced Plant-Based Glycan Engineering"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "126563806",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126563806",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Baiya Phytopharm Co., Ltd.",
        "Chulalongkorn University"
    ]
}